About this trial

This will be a single-center, single-arm, non-interventional natural history study to evaluate the longitudinal clinical course, functional outcome measures, and candidate biomarkers for individuals with DNA repair disorders, including Cockayne syndrome (CS), xeroderma pigmentosum (XP), and trichothiodystrophy (TTD).

Eligibility criteria

Qualifiers

Diagnosis of Cockayne syndrome (CS), xeroderma pigmentosum (XP), or trichothiodystrophy (TTD), based on genetic testing and/or key clinical characteristics l characteristics

Has one or more of the following neurodevelopmental or neurological complications

Gross motor delay (non-ambulatory or started walking after age 18 months)

Language delay (non-verbal or started talking after 18 months)

Disqualifiers

Any prior history of systemic gene or cell-based therapy

Current participation in an interventional clinical trial

Trial design

Treatments tested in this trial

  • Interval History
  • Physical Examination
  • ECAB Assessment
  • Gait Assessment
  • Specimen Sample Collection

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

1
University of Minnesota- Twin Cities55455, MinneapolisMinnesota, United States

Sponsors and collaborators

University of Minnesota

Lead sponsor